Ketamine Dosing for Refractory Status Epilepticus
For refractory status epilepticus (RSE) that has failed benzodiazepines and second-line agents, initiate ketamine with a loading dose of 1.5-2 mg/kg IV followed by continuous infusion starting at 1-2 mg/kg/hour, titrating up to 5-6 mg/kg/hour as needed for seizure control.
Dosing Regimen
Adults
- Loading dose: 1.5-2 mg/kg IV bolus over 2-5 minutes 1
- Maintenance infusion: Start at 1-2 mg/kg/hour, titrate by 0.5-1 mg/kg/hour increments every 15-30 minutes
- Maximum dose: Up to 5-6 mg/kg/hour (average effective dose 2.2 mg/kg/hour) 2
- Duration: Median 2-4 days, range 1-30 days 3, 2
Pediatrics
- Loading dose: 1-3 mg/kg IV bolus 3, 1
- Maintenance infusion: Start at 1 mg/kg/hour, titrate up to 6 mg/kg/hour as needed 4
- Infants: Can safely initiate at 1 mg/kg/hour without loading dose if hemodynamically unstable 4
Clinical Context and Timing
Ketamine should be considered as a third-line agent after failure of benzodiazepines plus one second-line antiseizure medication (phenytoin/fosphenytoin, valproate, or levetiracetam), though it is increasingly used earlier in the treatment algorithm 5. The evidence shows ketamine is typically added as the 4th antiseizure medication (mean 4.4 agents) 6.
Key Evidence for Efficacy
The strongest recent evidence demonstrates:
- 81% of patients achieve ≥50% seizure reduction within 24 hours 2
- 63% achieve complete seizure cessation 2
- Loading dose followed by maintenance is significantly more effective than maintenance alone (100% vs 36% control rate, P=0.01) 1
- Seizure termination occurs significantly faster when ketamine is added to midazolam compared to midazolam monotherapy (HR=1.895, P=0.025) 7
Administration Protocol
- Prepare infusion: Dilute to 1 mg/mL concentration for continuous infusion 8
- Give loading dose: 1.5-2 mg/kg IV over 2-5 minutes (can omit in hemodynamically unstable patients)
- Start maintenance: 1-2 mg/kg/hour continuous infusion
- Titrate: Increase by 0.5-1 mg/kg/hour every 15-30 minutes until seizures controlled or maximum 5-6 mg/kg/hour reached
- Monitor: Continuous EEG, vital signs, and hemodynamics
Combination Therapy
Ketamine is most commonly used adjunctively with midazolam or propofol (used concomitantly in 40-100% of cases) 3. This combination approach:
- Allows reduction of benzodiazepine infusion rates 4
- Provides synergistic seizure control through different mechanisms (NMDA antagonism vs GABA agonism)
- May enable faster seizure termination 7
Hemodynamic Advantages
Unlike GABAergic anesthetics, ketamine offers distinct cardiovascular benefits:
- Stable or improved blood pressure (OR 1.39 for maintaining MAP) 2
- Decreased vasopressor requirements over time 2
- No increase in intracranial pressure 2
- Particularly valuable in hemodynamically unstable patients or those with hypotension on other anesthetics 9
Safety Profile
Ketamine demonstrates excellent safety in RSE/SRSE:
- Mortality (38.8-59.5%) is related to underlying etiology, not ketamine 3
- Minimal adverse effects: Increased salivation (most common, manageable with antisialagogue) 1
- Well-tolerated in young infants without adverse events 4
- No respiratory depression compared to GABAergic agents 3
Common Pitfalls to Avoid
- Don't skip the loading dose: Studies show significantly better outcomes with loading dose followed by maintenance versus maintenance alone 1
- Don't underdose: Average effective dose is 2.2 mg/kg/hour; don't hesitate to titrate to 5-6 mg/kg/hour if needed 2
- Don't delay initiation: Earlier use (as 3rd-line rather than 4th or 5th) may improve outcomes 6
- Don't use as monotherapy initially: Ketamine works best adjunctively with midazolam or propofol 3, 7
- Don't withhold due to perceived contraindications: Concerns about hypertension (37% of providers), elevated ICP (24%), and heart failure (18%) are not supported by evidence 9
Monitoring Requirements
- Continuous EEG monitoring to assess seizure burden
- Continuous vital signs and hemodynamic monitoring
- Airway equipment immediately available (though respiratory depression is rare)
- Consider antisialagogue administration to manage increased secretions
The evidence strongly supports ketamine as an effective, safe option for RSE/SRSE with unique hemodynamic advantages over traditional GABAergic anesthetics 3, 2.